Please provide your email address to receive an email when new articles are posted on . An FDA panel voted that for adults with uncontrolled hypertension, the benefits of an ultrasound renal ...

National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained ...

Educated Patient® Kidney Cancer Summit Combination Therapy Panel: April 9, 2022 This panel featured Dr. Thomas Hutson, Dr. Saby George, Dr. Jeff Yorio, and Louise Gunter.

Please provide your email address to receive an email when new articles are posted on . An FDA panel voted that for adults with uncontrolled hypertension, the benefits of a radiofrequency renal ...

Update [Oct. 20]: Pazopanib gets FDA approval. There is probably no other cancer that has seen such breakthroughs in the past five years than kidney cancer. Less than a decade ago, patients with ...

The Paradise ultrasound renal denervation system got backing from the FDA's Circulatory System Devices Panel as a possible treatment for hypertension, as manufacturer ReCor continues to hope for ...

Professor of Medicine at Harvard Medical School and Senior Investigator in the Section on Genetics and Epidemiology at Joslin Diabetes Center in Boston, MA. To facilitate translational research on ...

An expert panel of US nephrologists and other health care providers unanimously agreed that secondary hyperparathyroidism treatment is often started too late in patients with chronic kidney disease. A ...

On Wednesday, the FDA's Circulatory System Devices Panel voted 6-7 (with one abstention) that the benefits of the Symplicity Spyral multi-electrode catheter system do not outweigh its risks when used ...

Hemotransfusion in treatment of anemia, 3D illustration showing two populations of red blood cells, small hypochromic red blood cells and normal. A small lymphocyte is drawn for size comparison The ...

Federal health advisers said Monday an experimental kidney cancer drug from GlaxoSmithKline PLC can benefit patients by slowing the disease, despite some risk of liver damage. The Food and Drug ...